BCRX vs HLT · rev $374.7M vs P/E 51, rev $6.28B
BioCryst Pharmaceuticals Inc (BCRX) versus Hilton Worldwide Holdings Inc (HLT) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported HLT revenue for 2026-06-30 was $6.28B. Net income was $867.0M. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
BCRX currently screens at market cap $1.83B. HLT currently screens at market cap $75.44B and trailing P/E 50.5.
Not investment advice. Open the BCRX and HLT stock pages for the full models.
Not investment advice.